Buy Acalnib 100mg Cap Acalabrutinib

Acalnib 100mg Cap contains acalabrutinib, a targeted therapy used in certain blood cancers. This oral capsule supports treatment plans for chronic lymphocytic leukemia and mantle cell lymphoma. Store at room temperature away from moisture and heat. Always follow your healthcare provider’s guidance.

Strength

100 mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Azista Bhutan Healthcare Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Acalnib 100mg Cap is prescribed for adults managing chronic lymphocytic leukemia or mantle cell lymphoma. It belongs to a class of medicines known as Bruton’s tyrosine kinase inhibitors. Patients often use it when other treatments have not been effective or as part of a combination therapy. This medication helps control disease progression by targeting specific cancer cells.

Side Effects

Acalnib 100mg Cap may help reduce symptoms such as fatigue, swollen lymph nodes, or night sweats associated with blood cancers. Some patients notice improved energy levels and reduced discomfort over time. Individual responses vary, and effects depend on the treatment plan and medical condition.

Precautions & Warnings

Keep Acalnib 100mg Cap in its original packaging at room temperature. Avoid exposing the capsules to moisture or direct sunlight. Do not open or crush the capsules unless advised by a healthcare professional. Inform your doctor about any other medications or supplements you are taking before starting this treatment.

Avoid Interactions

Acalnib 100mg Cap may interact with other drugs, including certain antibiotics, antifungals, or heart medications. Grapefruit and grapefruit juice can affect how this medicine works. Avoid alcohol unless cleared by your doctor. Always review your full medication list with a healthcare provider to prevent unwanted interactions.

References

Frequently Asked Questions

Acalnib 100mg Cap is used to treat chronic lymphocytic leukemia and mantle cell lymphoma in adults.

Store the capsules at room temperature, away from moisture and heat, in the original packaging.

Follow your doctor’s instructions; it can be taken with or without food unless otherwise advised.

Avoid grapefruit products and alcohol unless approved by your healthcare provider.

No, it should only be used under medical supervision due to potential interactions and side effects.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.